Literature DB >> 24145376

Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans.

F Papaleo1, M C Burdick2, J H Callicott2, D R Weinberger3.   

Abstract

Cognitive functions are highly heritable and the impact of complex genetic interactions, though undoubtedly important, has received little investigation. Here we show in an animal model and in a human neuroimaging experiment a consistent non-linear interaction between two genes--catechol-O-methyl transferase (COMT) and dysbindin (dys; dystrobrevin-binding protein 1 (DTNBP1))--implicated through different mechanisms in cortical dopamine signaling and prefrontal cognitive function. In mice, we found that a single genetic mutation reducing expression of either COMT or DTNBP1 alone produced working memory advantages, while, in dramatic contrast, genetic reduction of both in the same mouse produced working memory deficits. We found evidence of the same non-linear genetic interaction in prefrontal cortical function in humans. In healthy volunteers (N=176) studied with functional magnetic resonance imaging during a working memory paradigm, individuals homozygous for the COMT rs4680 Met allele that reduces COMT enzyme activity showed a relatively more efficient prefrontal engagement. In contrast, we found that the same genotype was less efficient on the background of a dys haplotype associated with decreased DTNBP1 expression. These results illustrate that epistasis can be functionally multi-directional and non-linear and that a putatively beneficial allele in one epistastic context is a relatively deleterious one in another. These data also have important implications for single-locus association analyses of complex traits.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145376      PMCID: PMC4845721          DOI: 10.1038/mp.2013.133

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  45 in total

1.  Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Authors:  Susheel Vijayraghavan; Min Wang; Shari G Birnbaum; Graham V Williams; Amy F T Arnsten
Journal:  Nat Neurosci       Date:  2007-02-04       Impact factor: 24.884

Review 2.  Imaging genetics--days of future past.

Authors:  Kristin L Bigos; Daniel R Weinberger
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

3.  Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

Authors:  G V Williams; P S Goldman-Rakic
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

4.  Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.

Authors:  M A Mehta; R Swainson; A D Ogilvie; J Sahakian; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2001-09-11       Impact factor: 4.530

5.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

6.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

7.  Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.

Authors:  Yukihiko Iizuka; Yoshitatsu Sei; Daniel R Weinberger; Richard E Straub
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

8.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

9.  Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice.

Authors:  Francesco Papaleo; Jacqueline N Crawley; Jian Song; Barbara K Lipska; Jim Pickel; Daniel R Weinberger; Jingshan Chen
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

10.  Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.

Authors:  James David Jentsch; Heather Trantham-Davidson; Corey Jairl; Matthew Tinsley; Tyrone D Cannon; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2009-07-29       Impact factor: 7.853

View more
  30 in total

1.  Gene dosage in the dysbindin schizophrenia susceptibility network differentially affect synaptic function and plasticity.

Authors:  Ariana P Mullin; Madhumala K Sadanandappa; Wenpei Ma; Dion K Dickman; Krishnaswamy VijayRaghavan; Mani Ramaswami; Subhabrata Sanyal; Victor Faundez
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

2.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

Review 3.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

4.  Generation and characterization of humanized mice carrying COMT158 Met/Val alleles.

Authors:  Victoria Risbrough; Baohu Ji; Richard Hauger; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2014-02-10       Impact factor: 7.853

Review 5.  Critical reappraisal of mechanistic links of copy number variants to dimensional constructs of neuropsychiatric disorders in mouse models.

Authors:  Noboru Hiroi
Journal:  Psychiatry Clin Neurosci       Date:  2018-03-01       Impact factor: 5.188

Review 6.  Translational genomics and beyond in bipolar disorder.

Authors:  Chen Zhang; Xiao Xiao; Tao Li; Ming Li
Journal:  Mol Psychiatry       Date:  2020-05-18       Impact factor: 15.992

Review 7.  The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions.

Authors:  H Chang; X Xiao; M Li
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

Review 8.  Systems psychopharmacology: A network approach to developing novel therapies.

Authors:  Peter J Gebicke-Haerter
Journal:  World J Psychiatry       Date:  2016-03-22

9.  Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.

Authors:  Francesca Managò; Maddalena Mereu; Surjeet Mastwal; Rosa Mastrogiacomo; Diego Scheggia; Marco Emanuele; Maria A De Luca; Daniel R Weinberger; Kuan Hong Wang; Francesco Papaleo
Journal:  Cell Rep       Date:  2016-08-11       Impact factor: 9.423

10.  Animal Models of Psychosis: Current State and Future Directions.

Authors:  Alexandra D Forrest; Carlos A Coto; Steven J Siegel
Journal:  Curr Behav Neurosci Rep       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.